NU.V - NeutriSci International Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.0800
-0.0100 (-11.11%)
As of 10:19AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0950
Open0.0950
Bid0.0800 x 0
Ask0.0950 x 0
Day's Range0.0800 - 0.0950
52 Week Range0.0650 - 0.2550
Volume22,000
Avg. Volume172,987
Market Cap9.006M
Beta (3Y Monthly)2.78
PE Ratio (TTM)N/A
EPS (TTM)-0.0230
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire6 days ago

    NeutriSci and Thai Freeze Dry Join Forces to Develop New Product Line of Cannabis Edibles

    The pilot formulation development and testing program to be conducted under this LOI shall focus on creation of test formulations of NeutriSci’s patented technology tablets to be modified through incorporation of TFD’s proprietary technology together with cannabinoids and other ingredients under TFD’s umbrella of products. Testing will be conducted at TFD’s facilities in Chiang Mai, Thailand.

  • GlobeNewswire19 days ago

    NeutriSci International Announces Exclusive Distribution Deal

    NeutriSci International Inc. ("NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® is pleased to announce effective May 1st, 2019 ANB Canada Inc. (“ANB”) will assume all responsibilities for retail sales and distribution of neuenergy® products in Canada. ANB not only markets, sells, warehouses and distributes consumer OTC brands, but also helps manufacturers in several areas, including generating brand awareness. ANB currently represents the brands of many manufacturers across many different product lines.

  • GlobeNewswire2 months ago

    NeutriSci Enters Into LOI With Falcon Technologies Inc. dba Eco-Growth Strategies to Manufacture Sublingual CBD Products

    NeutriSci has agreed to enter into this LOI with Falcon to create sublingual tablets for the delivery of dietary supplements including CBD in which these tablets can potentially create a product that has more efficient absorption rates than other CBD products. Upon the successful completion of a due-diligence period, both companies will work towards signing a definitive agreement in early Q2/2019.

  • ACCESSWIRE2 months ago

    Falcon Technologies aka Eco-Growth Strategies Enters Into LOI With Neutrisci To Manufacture Sublingual CBD Products

    SACRAMENTO, CA / ACCESSWIRE / March 25, 2019 / Neutrisci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and Falcon Technologies, Inc. ("Falcon") (FLCN:OTC PINK) are pleased to jointly announce they have entered into a Letter of Intent to create a sublingual CBD tablet. NeutriSci has agreed to enter into this LOI with Falcon to create sublingual tablets for the delivery of dietary supplements including CBD in which these tablets can potentially create a product that has more efficient absorption rates than other CBD products.

  • GlobeNewswire3 months ago

    Neutrisci Announces Product Sales Increase

    Neutrisci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that it has received its first order for its sublingual cannabidiol (CBD) tablets. This initial order will result in the Company reporting six figure sales for the current quarter. The quick dissolving, flavoured tablets are manufactured using the Company’s patent pending technology and offer a method to provide the consumer with a measured dose of known CBD product.

  • GlobeNewswire5 months ago

    NeutriSci Announces Exclusive Licensing Agreement for CBD Tablet Manufacturing & Distribution With LaSanta Botanicals Ltd.

    VANCOUVER, British Columbia, Dec. 06, 2018 -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer.